Method
Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.61% · OPTIONAL
· Pharmaceutical Preparations
RESEARCH SNAPSHOTSchrodinger, Inc.'s latest supported as-filed period reports revenue of $58.9M; gross margin moved 730 basis points higher on the same comparison basis. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.61% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -57.85% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 7.54% · CORE
Level · gp.fundamentals.gross_margin
Raw value 55.07% · CORE
Level · gp.fundamentals.operating_margin
Raw value -70.55% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 69.62% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +30.9% from the comparable as-filed period.
Gross margin changed +730 basis points from the comparable as-filed period.
Gross profit changed +24.0% from the comparable as-filed period.
Net income changed +113.8% from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
SDGR · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001490978-26-000068SEC ↗8-KAug 5, 2026Period Aug 5, 20260001490978-26-000067SEC ↗4Jul 17, 2026Period Jul 16, 20260002068195-26-000004SEC ↗4Jun 29, 2026Period Jun 26, 20260001798426-26-000004SEC ↗8-KJun 29, 2026Period Jun 29, 20260001490978-26-000059SEC ↗4Jun 23, 2026Period Jun 22, 20260001490978-26-000056SEC ↗4Jun 23, 2026Period Jun 22, 20260001610876-26-000003SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Jul 16, 2026Filed Jul 17, 2026 | Jain RachitEVP & CFO | Open Market SaleDirect | 875 | $16 | $13,647 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Raw value 14.93% · OPTIONAL
Operating income changed +21.5% from the comparable as-filed period.
Operating margin changed +2606 basis points from the comparable as-filed period.
Research & development changed -5.0% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001798426-26-000002